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INTRODUCTION:

ABSTRACT:
OBJECTIVE: With the recent surge in telepsychiatry utilization,
it is important to study the effectiveness of this virtual modality.
METHOD: To determine if telemedicine visits were effective in
keeping psychiatric patients stable, a retrospective study was
performed in an outpatient behavioral health setting using the
OQ®45.2/Y-OQ® 30.2 assessment tool, which assesses patient
reported outcomes across areas of functioning. To qualify for this
study, patients needed at least two OQ scores with one being
prior to the onset of telepsychiatry care and one being after
returning to in-person care.
RESULTS: 51.1% of adults (n=176) improved or remained the
same, whereas 48.8% deteriorated. Results indicated that 50.0%
of youth (n=22) improved or remained the same, whereas 50%
deteriorated. There were no significant differences in OQ scores
between gender, ethnicity, adult age groups, nor number of visits.
There were significant differences in adult OQ scores between
payer types, and youth OQ scores between different races.
CONCLUSION: It is important to note that this study was
conducted during the COVID-19 Pandemic, where, naturally,
many individuals were facing hardships; therefore, to improve or
remain the same during the pandemic is still an accomplishment.
By assessing total OQ scores among telemedicine patients, this
study is showing that telepsychiatry is a very valuable resource
for psychiatric patient care. Further research with a larger sample
size of qualifying patients is warranted especially post pandemic.

Correspondence to Adeolu Funso Oladunjoye
funsodunjoye@gmail.com
Disclosure Statement: The authors have no
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elemedicine is the use of computer
technology to deliver healthcare
from a distance.1 It involves meeting with, evaluating, and treating a patient
all in a virtual mode using either a video
platform or the telephone. Telemedicine
greatly improves the accessibility of patient care, especially for those living in
rural areas, without modes of transportation, and with limited financial resources.2 The use of telemedicine in Psychiatry
dates to the 1950s when physicians at the
University of Nebraska used a two-way
closed-circuit television to communicate
with their patients and conduct research.3
The usage became sporadic in the 1960s
and 1970s. It has been on the rise since
the 1990s, coinciding with the advances
in technology, access to smartphones and
other communication modalities, and
further understanding of both the psychiatric field and telemedicine.4 Its usage
has increased even more so since the onset of the COVID-19 Pandemic, where
mental health services are needed more
than ever, but in-person contact poses a
risk of infection.
The increased utilization of telepsychiatry visits during the COVID-19 Pandemic is due to several factors. First,
with the introduction of stay-at-home
orders during the beginning of the pandemic, many outpatients’ medical offices
had no choice but to change their visits
to telemedicine. This allowed providers
to continue care for patients throughout
the pandemic while keeping them safe
through social distancing and quarantining guidelines.5 In the NYU Langone
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Health System, telemedicine visits increased 683%
between March 2nd and April 14th of 2020.6 Furthermore, the pandemic put a huge strain on the
medical field as demonstrated with the well-known
shortages in medical equipment, such as personal protective equipment (PPE). 7 Telemedicine for
non-urgent outpatient care allowed for more resources to be allocated towards treating those diagnosed
with COVID-19 and chronic health conditions.5 Additionally, mental health professionals play a very
important role in alleviating the suffering associated
with the pandemic.7 Not only do global pandemics
cause a drastic increase in stress-related disorders
and mental health challenges, but these results are
long-lasting and will continue to increase the demand for telepsychiatry services.8
Research regarding the effectiveness of telemedicine in a psychiatric setting thus far has generated
overall positive results. A study performed by researchers at the University Clinic of Psychiatry in
Skopje found an 80.22% satisfaction rate among
telemedicine participants.9 A randomized controlled
trial (RCT) conducted by Ruskin et al on the management of patients with depression compared outcomes between groups randomized to telepsychiatry visits or in-person visits.10 Ruskin et al found
that patients who participated in telepsychiatry for
6 months showed comparable improvement to the
in-person group in their depression outcomes and
equivalent levels of patient adherence, satisfaction,
and health care cost.10 A systematic review of 10
studies looking at the effectiveness of telepsychiatry
in maternal depression found that 8 out of 10 of the
studies reported significant improvement in depression scores post telecare.11 Unfortunately, many of
these studies are limited by small sample size and
a lack of represented diagnoses. With the surge in
telepsychiatry services during the COVID-19 Pandemic, it is important to study the effectives of this
virtual modality. Therefore, the purpose of this study
was to determine whether the use of telepsychiatry
in an outpatient setting led to increased clinical stability. Stability was measured by measuring the patients’ OQ scores before beginning telepsychiatry
and comparing that to their OQ score after having
telepsychiatry services throughout the pandemic.
METHODS
This is a single center, retrospective study, of psychiatric patients in an outpatient setting. A chart review of the Electronic Medical Record (EMR) was
used to gather data about these patients. The patient
population studied includes all patients who were
© Tower Health
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seen in the psychiatry outpatient center. Data collected from charts included diagnoses, medications,
dates of telepsychiatry and outpatient visits, and the
number of outpatient visits, telepsychiatry visits,
hospitalizations, and emergency visits during the
study period. Demographic data including gender,
age range, race, ethnicity, and insurance type was
obtained for each patient.
Patients who received in-person psychiatric care prior to the onset of the COVID-19 Pandemic, telemedicine care during the COVID-19 Pandemic, and then
returned to in-person care at some point during the
pandemic were initially included in the study. Their
progress was monitored using the Outcome Questionnaire (OQ® 45.2/Y-OQ® 30.2) assessment tool.
The OQ® 45.2 was created by Dr. Lambert in 1996
and has become the most peer-reviewed patient-reported outcome measure used globally.12 This is a
self-reported tool designed to monitor a wide range
of mental health characteristics over the course of
treatment. It is quick to administer, making it easy for
routine use. It consists of 45 questions that report a
total score as well as Symptoms Distress score, Interpersonal Relations score, and Social Role score for
adults. The higher the score, the more distressed the
individual.12 Similarly, the Y-OQ® 30.2 consists of
30 questions that report a total score as well as Somatic score, Social Isolation score, Conduct Problems
score, Aggression score, Hyperactivity/Distractibility
score, and Depression/Anxiety score for children and
adolescents.13 These tools have proven to have stable
scores across time outside of a treatment setting and
have a high sensitivity to changes in psychological
functioning over short periods of time.14 Furthermore,
it provides objective measurements in the assessment
of clinical improvement and deterioration.15 At this
outpatient behavioral health setting, it was only administered during in-person visits. The adult version
ranges from 0-180 points whereas the youth version
ranges from 0-120 points.16,17 A score above 63 for
adults and 29 for youth indicates that the patient has
many symptoms of distress, such as anxiety, depression, and stress, as well as interpersonal difficulties
in their personal life.16,17 In contrast, a score below
those values suggests that the patient is functioning
in the same range as anyone from the general population.16,17
To qualify for this study, patients needed at least two
OQ scores with one being prior to the onset of telepsychiatry care and one being after returning to
in-person care. 176 adults and 22 youth qualified
for this study, which is only 33% of the total patient
population. Their total score was calculated, which
is their final OQ score minus their first OQ score pri-
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Table 1. Sample Demographics
Characteristic

N

(%)

73

36.9

125

63.1

155

78.3

African American

12

6.1

Other

27

13.6

4

2.0

43

21.7

153

77.3

2

1.0

12-17

22

11.1

18-29

48

24.2

30-49

73

36.9

50-64

42

21.2

65 and above

13

6.6

Medicare

41

20.7

Medicaid

20

10.1

128

64.6

9

4.5

19

9.6

7

3.5

25

12.6

Autism Spectrum Disorder

5

2.5

Bipolar or Related Disorder

36

18.2

Depressive Disorder

73

36.9

Disruptive Behavior Disorder

3

1.5

Eating Disorders

1

0.5

Personality Disorders

2

1.0

12

6.1

1

0.5

14

7.1

Gender
Male
Female

Race
Caucasian

Unknown

Ethnicity
Hispanic or Latino
Non-Hispanic or Latino
Unknown

Age Range

Payer Type

Private Insurance
Self-Pay

Diagnosis
ADHD
Adjustment Disorder
Anxiety Disorder

Schizophrenic or Psychotic Disorder
Substance Related Disorder
Trauma or Stress Related Disorder
© Tower Health
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or to the pandemic.16,17 An improvement is defined
as a decrease in OQ score by any amount, whereas
a statistical improvement is defined as a decrease of
14 points or more for adults and 10 points or more
for youth.16,17 The same definitions apply to a deterioration and significant deterioration with an increase
of either 14 points or 10 points respectively.16,17 By
calculating the change in patients’ OQ scores, we
were able to determine if the patients improved,
deteriorated, or remained the same throughout telemedicine services. The reference to the statistical
significance of a 14 point change for adults and a
10 point change for children came from the manuals
for the OQ® 45.2/Y-OQ® 30.2, which is based on
development research.16,17
Study data were collected and managed using REDCap electronic data capture tools hosted at Tower
Health.18,19 After the completion of data collection, the
data was exported into Statistical Package for the Social Sciences (SPSS version 28.0) for statistical analysis. Summary statistics were made using proportions,
mean/median and standard deviation/interquartile
range. The level of significance was set at p<0.05.
RESULTS
Demographic variables collected include race, ethnicity, and age (Table 1). The sample population
was representative of the overall practice population
regarding race, ethnicity, and mental health diagnoses. The study determined that 48.3% of adults
improved or significantly improved, 2.8% remained
the same, and 48.9% deteriorated or significantly
deteriorated throughout the use of telepsychiatry
care. 36.4% of youth improved or significantly improved, 13.6% remained the same, and 50% deteriorated or significantly deteriorated (Figure 1). The
average OQ score before onset of care was 67.31 for
adults and 35.86 for youth; the average OQ score
post-telepsychiatry was 67.29 for adults and 38.86
for youth (Figure 2). In the adult population, there
were no statistically significant differences in outcomes between race, gender, ethnicity, age ranges, number of telemedicine visits, nor diagnoses
(Figure 3A). A statistically significant difference in
outcome was found between adult payer type, with
those with private insurance having better outcomes
(p=0.000) (Figure 4). In the youth population, there
were no statistically significant differences in outcomes between gender, ethnicity, age ranges, payer
type, number of telemedicine visits, nor diagnoses
(Figure 3B). A statistically significant difference in
outcome was found between youth races with those
that identify as Black or African American having
better outcomes (p=0.033).
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Average OQ Score for Outpatients
Before and After Telemedicine

Adult OQ Score Results

Significantly
Deteriorated
19.32%

80

Average OQ Score

Deteriorated
29.53%

Significantly
Improved
15.92%

Improved
32.43%

70

67.30

Average OQ Score
Before Telemedicine

67.29

Average OQ Score
After Telemedicine

60
50

35.86

40

38.86

30
20
10

No Change
2.80%

0

Youth OQ Score Results
Significantly
Improved
18.20%

Significantly
Deteriorated
22.70%

Deteriorated
27.30%

Improved
18.20%
No
Change
13.60%

Figure 1. Adult and Youth Total OQ Score Results. 51.1% of adults significantly improved,
improved, or remained the same, whereas
48.9% deteriorated or significantly deteriorated. Significance for the adult OQ indicates
a 14-point change in either direction. 50% of
youth significantly improved, improved, or
remained the same, whereas 50% significantly
deteriorated
DISCUSSION
It is important to emphasize that the study was conducted during the COVID-19 Pandemic, which has
caused and contributed to a tremendous amount of
suffering world-wide. As society has been forced to
adapt to a new way of living while managing their
concerns and fears over the health of themselves and
loved ones, and their finances in the wake of numerous layoffs, the mental health of society has taken
many hits. This pandemic may have also exacerbated mental health concerns and conditions in susceptible individuals. When taking this into account, it is
remarkable that 51.1% of adults and 50.0% of children/adolescents ages 12 to 17 improved or remained
the same in this study. This is an accomplishment in
and of itself. Considering that this study took place
during a pandemic, it is hypothesized that there may
© Tower Health
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Adult

OQ Type

Youth

Figure 2. Average Total OQ Scores Before
and After Receiving Telemedicine Care. The
OQ Assessment tool was used to assess patient
reported outcomes with respect to their mental
health. The average OQ scores for both adult
and youth individuals were calculated both
prior to and after undergoing telemedicine. The
Adult OQ assessment tool has scores ranging
from 0-180, with a score of 63 or more indicating symptoms of clinical significance. The
Youth OQ assessment tool has scores ranging
from 0-120, with a score of 29 or more indicating symptoms of clinical significance.

have been more individuals improving or remaining
the same had the study been conducted outside of a
global pandemic.
An important limitation with this study is the fact
that the sample population is not truly
representative of the actual patient population at this
clinic. This is because only 33% of the patient population qualified for the study. Therefore, we cannot
generalize findings to the entire population. Many
patients were eliminated for not having an OQ score
before and/or after the onset of telepsychiatry and
for discontinuing care. This is important as those
who discontinued care may have done so because
they were afraid to leave their homes due to the pandemic and/or were unable to connect through telemedicine. Some of the patients who were eliminated
for not having a follow-up OQ were still attending
sessions using telemedicine; these patients did not
have a follow-up OQ since these questionnaires are
only administered during in-person visits. If any of
these groups had returned to in-person outpatient
visits, they would have undergone another OQ as-

Transform Med | Vol 1, No 3. September 2022 | https://doi.org/10.54299/tmed/pbye5667

49

Number of patients

35
30
25

Ray et al.

Prevalence and Outcomes of the Use of Telemedicine for Psychiatry Patients in Female
the Outpatient Setting

A. Adult Male vs. Female Outcomes

20
15
10
5

40

0

30
25
20

No
Change

Deteriorated Significanlty
Deteriorated

B. Youth Male vs. Female Outcomes

15

15

10

10

Male

5
0

Significanlty Improved
Improved

Outcome
Female

Number of
patients

Number of patients

35

Male

Significanlty Improved
Improved

No
Change

Deteriorated Significanlty
Deteriorated

5
0

Female
Male
Significanlty Improved
Improved

Outcome

No
Change

Deteriorated Significanlty
Deteriorated

Outcome

5
0

Female
Male

Significanlty Improved

No

Deteriorated Significanlty

Deteriorated
Improved
sessment;
therefore, it isChange
possible the data
would
Outcome
have shown more patients
in the improved or significantly improved category. Furthermore, 61.1%
of the sample population had private insurance,
which is the opposite of what occurs in the practice
setting; prior data has shown that the payer split is
60% public insurance (Medicare and Medicaid) and
40% private insurance for this patient population.
Additionally, although we did not find statistically
significant differences between adult subpopulations
within our research study, it is important to note that
there were not equal distributions of gender, race,
ethnicity, and age range. For example, there were
almost twice as many women than men (114 vs.
62, respectively). There was also a disproportionate
amount of non-Hispanic (77.8% of the adult population) and White (81.8% of the adult population)
individuals. This makes it difficult to generalize the
findings between sub-populations.
There was a statistically significant difference between payer type in the adult population; however,
this may be skewed. An important implication of
those that were eligible for this study is the necessity for computer or smartphone access with excellent
Wi-Fi connection to participate in Video Telemedicine for the best therapy results. Therefore, it is possible that some individuals were unable to continue
care during the pandemic if they did not have access
to technological resources. This is an important consideration that warrants further research, especially
since it has been documented that those with lower
income, who may be unable to afford such resources, have worse health outcomes. In research conducted by Rajasekaran, it was found that about 30%

© Tower Health

Adult Patient Outcome by Payer Type
40

Self-Pay

35

Private
Insurance
Medicaid

30

Number of patients

Number of
patients

B. Youth
Malevs.
vs.Female
Female
Outcomes
Figure
3. Male
Outcomes.
A. There is no significant difference in outcomes between
15
genders
within the adult population (p=0.281). B. There is no significant difference in outcome
10
between gender within the youth population (p=0.699).

Medicare

25
20
15
10
5
0

Significanlty Improved
Improved

No
Change

Deteriorated Significanlty
Deteriorated

Outcome

Figure 4. Adult Patient Outcomes Based on
Payer Type. There were statistically significant
outcomes between payer type for the adult
population, with those with private insurance
having better outcomes (p=0.001). It is important to note that the payer split between private
insurance and all other pay-types was 60:40,
whereas historically at this behavioral health
outpatient services clinic, it has been the opposite: 60% public insurance, 40% private.
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of patients in an otolaryngology practice were not
able to participate in telemedicine due to their lack
of access to technological resources. This researcher described this phenomenon as a “digital divide”
which can present a challenge to the older and less
educated patients that suffer poorer health outcomes
and have a more difficult time accessing telemedicine technology.20
There was a statistically significant difference between youth race groups; however, this is skewed
due to the small sample size of only 22 youth. Of
the 22 youths, 11 identified as White or Caucasian,
4 as Black or African American, 4 as Other, and 3
were marked as unknown. Due to the disproportionate amount of White/Caucasian youth compared to
the other groups, it is difficult to make any accurate
assumptions. Furthermore, only 41.5% of the youth
patient population qualified for this study. Research
conducted by Dong et al has shown that youth have
struggled with the transition to online learning in the
school setting.21 It is also important to consider that
the transition to telemedicine may have been especially difficult for this patient population too. In a
systematic review conducted by Jones et al, researchers found that adolescents world-wide have higher
rates of anxiety, depression, stress, and substance use
than previously reported. These researchers also noted that positive coping skills and social support can
help mitigate these mental health concerns.22 It is important to investigate what obstacles prevent patients
from participating in telemedicine so that no specific
subpopulations are inadvertently excluded, and so
that they can receive appropriate treatment.
The retrospective nature of this study led to some
flaws. Prior to the beginning of the COVID-19 Pandemic, the OQ® 45.2/Y-OQ® 30.2 questionnaires
were only administered at set intervals during in-person visits only. With the abrupt change to telemedicine during the pandemic, a system was not in place
to administer these questionnaires electronically.
In this retrospective study, the questionnaires were
used as an assessment for clinical improvement;
therefore, all patients that did not return to in-person visits automatically did not qualify for the study
since we would not be able to calculate a total OQ
score for them. If this was a prospective study, then
a system could have been set up ahead of time to administer OQ® 45.2/Y-OQ® 30.2 electronically and
to ensure patient access to telemedicine. If the study
was set up prospectively in that manner, then more
patients would have qualified for this study and the
issue of losing patients due to lack of internet access
could have been mitigated. Nonetheless, this study
provides direction for future studies.
© Tower Health
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CONCLUSION
As telemedicine has become increasingly utilized,
especially since the beginning of the COVID-19
Pandemic, it has become extremely important to
assess the utility of this virtual modality. Several
studies have used the OQ® 45.2/Y-OQ® 30.2 assessment tool as a measure of patient progress, making this tool appropriate to assess clinical stability
in telemedicine patients. To date, no similar studies
using this tool in the context of telemedicine exist.
By assessing total OQ scores among telemedicine
patients, this study has established that telepsychiatry is a very valuable resource moving forward with
psychiatric patient care. However, more research
with a larger sample size and higher percentage of
qualifying patients should be conducted at a time
when the 
COVID-19 Pandemic is not wreaking
havoc on the emotional state of individuals to adequately assess the effectiveness of telepsychiatry at
increasing clinical stability.
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